Double-Blind, Placebo-Controlled Randomized Trial on Low Dose Azithromycin Prophilaxis in Primary Antibody Deficiencies
BACKGROUND:
Lacking protective antibodies, patients with Primary Antibody Deficiencies (PAD) suffer from frequent respiratory infections leading chronic pulmonary damage. Macrolides prophylaxis has been proven effective in chronic respiratory diseases.
OBJECTIVE:
We aimed to test the efficacy and safety of orally administered low-dose azithromycin prophylaxis in PAD patients.
METHODS: